Skip to main content

Supernus Pharmaceuticals, Inc.

SUPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001356576

No open-market purchases or sales by Supernus Pharmaceuticals, Inc. insiders were filed in the last 90 days; 334 institutions reported holding it in 13F filings for Q2 2026, worth $2.80B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Supernus Pharmaceuticals, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
226
+3 vs. Q1 2021
Shares held
54.2M
+862.7K (+1.6%) vs. Q1 2021
Total value
$1.67B
+$271.6M (+19.4%) vs. Q1 2021
New holders
30
74 more added
Sold out
27
85 more reduced

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SUPN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 226 institutions
Q1 2021: 224 institutionsQ2 2021: 226 institutionsQ3 2021: 224 institutionsQ4 2021: 235 institutionsQ1 2022: 230 institutionsQ2 2022: 225 institutionsQ3 2022: 244 institutionsQ4 2022: 264 institutionsQ1 2023: 259 institutionsQ2 2023: 249 institutionsQ3 2023: 239 institutionsQ4 2023: 245 institutionsQ1 2024: 251 institutionsQ2 2024: 245 institutionsQ3 2024: 273 institutionsQ4 2024: 294 institutionsQ1 2025: 295 institutionsQ2 2025: 295 institutionsQ3 2025: 310 institutionsQ4 2025: 333 institutionsQ1 2026: 328 institutionsQ2 2026: 334 institutions
Value heldQ2 2021: $1.67B
Q1 2021: $1.40BQ2 2021: $1.67BQ3 2021: $1.45BQ4 2021: $1.61BQ1 2022: $1.75BQ2 2022: $1.58BQ3 2022: $1.88BQ4 2022: $1.99BQ1 2023: $2.01BQ2 2023: $1.72BQ3 2023: $1.57BQ4 2023: $1.65BQ1 2024: $1.93BQ2 2024: $1.56BQ3 2024: $1.87BQ4 2024: $2.15BQ1 2025: $1.94BQ2 2025: $1.87BQ3 2025: $2.76BQ4 2025: $2.84BQ1 2026: $3.01BQ2 2026: $2.80B
Institutions holding SUPN and their total value by quarter
QuarterHoldersValue
Q2 2026334$2.80B
Q1 2026328$3.01B
Q4 2025333$2.84B
Q3 2025310$2.76B
Q2 2025295$1.87B
Q1 2025295$1.94B
Q4 2024294$2.15B
Q3 2024273$1.87B
Q2 2024245$1.56B
Q1 2024251$1.93B
Q4 2023245$1.65B
Q3 2023239$1.57B
Q2 2023249$1.72B
Q1 2023259$2.01B
Q4 2022264$1.99B
Q3 2022244$1.88B
Q2 2022225$1.58B
Q1 2022230$1.75B
Q4 2021235$1.61B
Q3 2021224$1.45B
Q2 2021226$1.67B
Q1 2021224$1.40B

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Supernus Pharmaceuticals, Inc.; share changes are against Q1 2021.

Institutions holding SUPN in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
HealthInvest Partners AB530,000$16.3M15.46%−4,000−0.7%Reduced
Glenmede Trust Co NA567,929$17.5M0.09%−1,532−0.3%Reduced
Bank of America Corp582,051$17.9M0.00%+21,788+3.9%Added
Price T Rowe Associates Inc607,393$18.7M0.00%−990−0.2%Reduced
Bank of New York Mellon Corp609,294$18.8M0.00%−47,384−7.2%Reduced
Victory Capital Management Inc638,878$19.7M0.02%+217,931+51.8%Added
Northern Trust Corp674,248$20.8M0.00%+84,391+14.3%Added
Invesco Ltd.758,403$23.4M0.01%+31,120+4.3%Added
Ameriprise Financial Inc803,241$24.7M0.01%+38,264+5.0%Added
Frontier Capital Management Co LLC816,731$25.1M0.18%+47,208+6.1%Added
Geode Capital Management, LLC905,691$27.9M0.00%+36,067+4.1%Added
Rice Hall James & Associates, LLC922,859$28.4M1.01%−112,230−10.8%Reduced
Ashford Capital Management Inc1,000,972$30.8M2.78%−230,256−18.7%Reduced
Aristotle Capital Boston, LLC1,061,653$32.7M0.75%+88,360+9.1%Added
FMR LLC1,240,095$38.2M0.00%+434,521+53.9%Added
Stephens Investment Management Group LLC1,245,329$38.3M0.53%+104,810+9.2%Added
Renaissance Technologies LLC1,516,222$46.7M0.06%−244,000−13.9%Reduced
GW&K Investment Management, LLC1,616,100$49.8M0.43%+42,689+2.7%Added
Loomis Sayles & Co L P1,619,065$49.9M0.06%+1,186,742+274.5%Added
State Street Corp1,827,480$56.3M0.00%+49,818+2.8%Added
Macquarie Group Ltd2,135,923$65.8M0.05%+52,205+2.5%Added
Dimensional Fund Advisors LP2,276,185$70.1M0.02%+144,093+6.8%Added
Armistice Capital, LLC3,324,000$102.3M2.72%−88,000−2.6%Reduced
Vanguard Group Inc5,484,424$168.9M0.00%+29,869+0.5%Added
BlackRock Inc.8,872,052$273.2M0.01%−122,174−1.4%Reduced
Sofos Investments, Inc.104––−17−14.0%Reduced
Prudential PLC0$00.00%−242,100−100.0%Sold out
Federated Hermes, Inc.0$00.00%−195,947−100.0%Sold out
Jefferies Group LLC0$00.00%−112,500−100.0%Sold out
California Public Employees Retirement System0$00.00%−99,700−100.0%Sold out
Voloridge Investment Management, LLC0$00.00%−57,283−100.0%Sold out
Mackay Shields LLC0$00.00%−39,200−100.0%Sold out
Squarepoint Ops LLC0$00.00%−22,764−100.0%Sold out
Martingale Asset Management L P0$00.00%−22,221−100.0%Sold out
Acadian Asset Management LLC0$00.00%−13,258−100.0%Sold out
Jane Street Group, LLC0$00.00%−12,902−100.0%Sold out
Malaga Cove Capital, LLC0$00.00%−11,890−100.0%Sold out
Man Group plc0$00.00%−10,900−100.0%Sold out
AQR Capital Management LLC0$00.00%−8,942−100.0%Sold out
Paloma Partners Management Co0$00.00%−8,632−100.0%Sold out
Dynamic Technology Lab Private Ltd0$00.00%−8,309−100.0%Sold out
C M Bidwell & Associates Ltd0$00.00%−7,725−100.0%Sold out
Wolverine Trading, LLC0$00.00%−7,641−100.0%Sold out
Quantbot Technologies LP0$00.00%−1,731−100.0%Sold out
Group One Trading, L.P.0$00.00%−1,584−100.0%Sold out
Versant Capital Management, Inc0$00.00%−559−100.0%Sold out
Clearstead Advisors, LLC0$00.00%−100−100.0%Sold out
Alpha DNA Investment Management LLC0$00.00%−87−100.0%Sold out
Allred Capital Management, LLC0$00.00%−75−100.0%Sold out
Ameritas Investment Company, LLC0$00.00%−63−100.0%Sold out
Denali Advisors LLC0$00.00%−38−100.0%Sold out
Sowell Financial Services LLC0$00.00%−36−100.0%Sold out
RWM Asset Management, LLC0$00.00%−29−100.0%Sold out
BBVA USA Bancshares, Inc.––––Not filed